By making a commitment to affordability and opening the door to greater collaboration to reduce out-of-pocket medication spending, we can ensure that more people are able to reap the health benefits of these critical medications
People who lost weight using medication were often judged more negatively than those who lost weight through lifestyle changes, and individuals who regained weight after stopping treatment also experienced social bias
[6] [14] Effects on long-term cardiovascular outcomes remain limited, and weight loss in the general population is not an approved use
Progress does not require perfection
Novo Nordisk is also exploring innovative treatments, such as CagriSema, a combination of semaglutide and cagrilintide
[4] This guide unpacks the gutGLP-1 axis : how a diverse microbiome and the prebiotic fiber that feeds it are connected to your body's natural GLP-1 production, what the peer-reviewed evidence actually shows about fiber, short-chain fatty acids, foods, and specific probiotic species, and how to build an everyday routine that supports the gut environment where this hormone is made
